SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-017724
Filing Date
2023-05-04
Accepted
2023-05-04 14:41:40
Documents
82
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eypt-20230331.htm   iXBRL 10-Q 2485013
2 EX-31.1 eypt-ex31_1.htm EX-31 16758
3 EX-31.2 eypt-ex31_2.htm EX-31 17206
4 EX-32.1 eypt-ex32_1.htm EX-32 7281
5 EX-32.2 eypt-ex32_2.htm EX-32 7326
  Complete submission text file 0000950170-23-017724.txt   9950823

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eypt-20230331_pre.xml EX-101.PRE 425152
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eypt-20230331_def.xml EX-101.DEF 263452
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eypt-20230331_cal.xml EX-101.CAL 64514
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eypt-20230331.xsd EX-101.SCH 73317
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eypt-20230331_lab.xml EX-101.LAB 570107
76 EXTRACTED XBRL INSTANCE DOCUMENT eypt-20230331_htm.xml XML 1942767
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51122 | Film No.: 23888021
SIC: 3826 Laboratory Analytical Instruments
Industrial Applications and Services